Cite
HARVARD Citation
Radhakrishnan, S. et al. (2017). Elotuzumab as a novel anti-myeloma immunotherapy. Human vaccines & immunotherapeutics. 13 (8), pp. 1751-1757. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Radhakrishnan, S. et al. (2017). Elotuzumab as a novel anti-myeloma immunotherapy. Human vaccines & immunotherapeutics. 13 (8), pp. 1751-1757. [Online].